Reimbursement for our products depends on the type of payer
involved and the setting in which our products are used.
Our products are rented or sold to hospitals, extended care
facilities and directly to patients or via a prescription to
patients at home. Payment is received from various public and third
party payers, including government-funded programmes.
V.A.C.® Therapy is eligible for coverage in several
European countries. For the majority of European countries that are
not yet covered, applications for reimbursement are in progress,
while in some countries we have part-coverage with public and third
party payers.
For more information on the reimbursement of KCI products in
your country, please contact KCI Europe Holding B.V.:
T: +31 (0)20 426 0000
F: +31 (0)20 426 0099
E-mail: info@kci-medical.com